Inozyme Pharma, a clinical-stage rare disease biopharmaceutical company developing novel therapeutics for the treatment of abnormal mineralization, entered into a debt financing facility for up to $70 million with K2 HealthVentures (K2HV), a...
Read Story
|
Impel NeuroPharma announced two separate transactions with funds managed by Oaktree Capital Management totaling $100 million in gross funding. The transactions include a $50 million royalty agreement on net sales of the nasal spray, Trudhes, and $50...
Read Story
|
Bausch Health Companies announced that it is seeking to refinance its existing credit agreement (the "Credit Agreement" and such refinancing, the "Credit Agreement Refinancing"). The refinanced Credit Agreement is expected to consist of approximately...
Read Story
January 19, 2022, 07:00 AM
|
Eloxx Pharmaceuticals entered into a debt facility of up to $30.0 million with Hercules Capital. Eloxx has drawn the initial tranche of $12.5 million and used the proceeds to repay in full amounts outstanding under the Company’s existing debt...
Read Story
October 07, 2021, 08:00 AM
|
Xeris Pharmaceutical entered into an amendment to its existing loan and security agreement with Oxford Finance LLC (Oxford) and Silicon Valley Bank (SVB). The amendment allows for extensions of interest-only payments for up to 12 months, subject to...
Read Story
|
SG Credit Partners provided a $3.35 million loan to a pharmaceutical products company structured primarily around the founder’s personal assets (real estate and marketable securities). SG’s speed to close allowed the Company to close the asset...
Read Story
January 28, 2021, 05:00 AM
|
Corbus Pharmaceuticals Holdings, a clinical-stage drug development company pioneering transformative medicines that target the endocannabinoid system, announced it has received an aggregate of $71 million in gross proceeds from its at-the-market...
Read Story
|
Fennec Pharmaceuticals Inc., a specialty pharmaceutical company focused on the development of PEDMARK™ (a unique formulation of sodium thiosulfate) for the prevention of platinum-induced ototoxicity in pediatric patients, today announced an amendment...
Read Story
|
MidCap Business Credit completed a $5 million revolving credit facility for Appco Pharma, LLC. The facility was used to provide additional liquidity and support the company’s growth plans and working capital needs.Appco is a privately owned and...
Read Story
|
In an attempt to gain a foothold in the cash-laden tech industry, some biotechnology and pharmaceutical companies have begun snapping up choice digital health companies, with a few billion-dollar deals leading the trend.Digital health deal values in...
Read Story
December 13, 2019, 09:00 AM
|
Rigel Pharmaceuticals, Inc. announced that it has entered into a $60 million term loan credit facility with MidCap Financial (MidCap). At closing, $10 million was funded to Rigel in an initial tranche. The facility also gives Rigel the ability to...
Read Story
October 02, 2019, 09:00 AM
|
Optinose, a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today reported that it has entered into a note purchase agreement for up to $150 million of senior secured notes with funds managed...
Read Story
September 16, 2019, 08:00 AM
|
ObsEva SA, a Swiss clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious conditions that compromise a woman's reproductive health and pregnancy, announced the closing of a $75...
Read Story
August 07, 2019, 08:00 AM
|
Antares Pharma, Inc. announced that it has entered into an amendment to its existing loan and security agreement with Hercules Capital, Inc. (HTGC), to increase the available debt capital by $25 million for a term loan of up to $50 million. The...
Read Story
|
MidCap Business Credit completed an $8 million Revolving Credit Facility for Sovereign Pharmaceuticals, LLC. The facility was used to refinance the company’s existing senior debt and to support the company’s growth plans and working capital...
Read Story
January 02, 2019, 09:00 AM
|
Nevakar Inc., a specialty pharmaceutical company developing multiple differentiated products in the ophthalmic and injectable areas, announced that it has entered into a $20 million senior secured term loan with Oxford Finance LLC. As part of the...
Read Story
December 03, 2018, 08:00 AM
|
Monroe Capital LLC announced an increase in its credit facility to ProPharma Group (ProPharma) to support the acquisition of Xendo Holding B.V. (Xendo). ProPharma is an existing portfolio company of Linden Capital Partners. Based in the Netherlands...
Read Story
August 21, 2018, 08:00 AM
|
Capitala Group, a provider of capital to lower and traditional middle market companies, announced that it recently originated a combination of a senior secured debt facility and minority equity totaling $27.3 million to support Cold Bore Capital in...
Read Story
|
XOMA Corporation, a pioneer in the discovery, development and licensing of therapeutic antibodies, announced it has entered into a flexible $20 million credit facility with Silicon Valley Bank, with availability through March 2019.“This credit...
Read Story
|
Tricida, Inc., a South San Francisco, CA-based late-stage pharmaceutical company, entered into a $100 million venture debt facility with Hercules Capital, Inc.
Tricida drew down $25 million from the venture debt facility at closing. An additional...
Read Story
|
Molecular Templates, a clinical stage biopharmaceutical company focused on the discovery and development of Engineered Toxin Bodies (ETBs), a new class of targeted biologic therapies that possess unique mechanisms of action in oncology, announced the...
Read Story
|
Verastem, Inc., focused on discovering and developing drugs to improve the survival and quality of life of cancer patients, announced its entry into an amendment to its Loan and Security Agreement with Hercules Capital, Inc., increasing its existing...
Read Story
January 05, 2018, 07:15 AM
|
Midatech, the international specialty pharmaceutical company focused on developing and commercializing products in oncology, announced that it has entered into a four-year senior secured loan agreement with MidCap Financial of up to $15...
Read Story
January 02, 2018, 07:00 AM
|
Nuvo Pharmaceuticals Inc., a commercial healthcare company with a portfolio of commercial products and pharmaceutical manufacturing capabilities, announced that it has secured a $6.0 million operating revolving credit facility with Royal Bank of...
Read Story
August 25, 2017, 08:00 AM
|
Presidential Financial Corporation announced it has provided a $15 million working capital facility to Unicare Pharmacy.
Headquartered in Van Nuys, California, Unicare operates as a family-owned and operated closed-door pharmacy. It provides...
Read Story
August 11, 2017, 08:00 AM
|
Ashland Global Holdings Inc. announced that its indirect, wholly owned subsidiary, Ashland LLC is seeking to obtain a new $600 million 7-year senior secured term loan B facility to retire the company's 3.875% senior notes due 2018.In addition, the...
Read Story
|
Square 1 Bank, a division of Pacific Western Bank, announced that it has provided a $4 million credit facility to new client Recursion Pharmaceuticals, Inc., a leading pharmaceutical discovery company. Proceeds from the facility will be used to...
Read Story
February 08, 2017, 07:22 AM
|
Deloitte Corporate Finance LLC acted as financial advisor to Houston-based Advanced Pharma, Inc. (Advanced Pharma) on its sale to Avella Specialty Pharmacy (Avella). Advanced Pharma is an FDA-registered 503B Outsourcing Facility providing compounded...
Read Story
February 06, 2017, 08:00 AM
|
Parnell Pharmaceuticals Holdings Ltd, a fully integrated pharmaceutical company focused on developing, manufacturing and commercializing innovative animal health solutions, announced that it has entered into a $20 million, senior secured...
Read Story
November 23, 2016, 07:31 AM
|
aTyr Pharma, Inc., a biotherapeutics company engaged in the discovery and development of Physiocrine-based therapeutics to address severe, rare diseases, announced it has entered into a $20 million credit facility with Silicon Valley Bank (SVB) and...
Read Story
November 22, 2016, 07:08 AM
|
Valeant Pharmaceuticals International, Inc. announced that it has obtained the requisite lender approval for an amendment to its credit facility. The company expects to close the amendment next week, subject to customary closing conditions. The...
Read Story
August 22, 2016, 07:28 AM
|
MonoSol Rx, a specialty pharmaceutical company leveraging its PharmFilm drug delivery technology to improve patient outcomes and to address unmet needs, announced the closing of a $50 million credit facility with Perceptive Advisors. The proceeds...
Read Story
August 19, 2016, 07:27 AM
|
Regulus Therapeutics Inc., a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, announced it has entered into a $30 million loan and security agreement with Oxford Finance. Proceeds from the...
Read Story
|
Maranon Capital, L.P. announced that it provided unitranche financing to support the acquisition of a majority interest in Wedgewood Pharmacy by New Harbor Capital.Wedgewood, headquartered in Swedesboro, NJ, is an industry leading provider of...
Read Story
|
Omeros Corporation announced that it has entered into an amendment to its existing credit facility with Oxford Finance LLC and East West Bank to provide the company with an additional $20 million in unrestricted cash by funding the remaining tranches...
Read Story
|
CIT Group announced that CIT Healthcare Finance served as Sole Lead Arranger and Administrative Agent for a $50 million senior secured credit facility to Superior Biologics, a leading home infusion and specialty pharmacy provider offering services to...
Read Story
|
Mast Therapeutics, Inc., a biopharmaceutical company developing novel, clinical-stage therapies for sickle cell disease and heart failure, announced that it has entered into an amendment to its existing $15 million debt facility with Hercules Capital...
Read Story
|
Acerus Pharmaceuticals Corporation reported that it has entered into an agreement to amend its senior secured term credit facility with an affiliate of MidCap Financial, LLC.Pursuant to the terms and conditions of this amendment, the company will...
Read Story
December 14, 2015, 07:09 AM
|
Sucampo Pharmaceuticals, Inc., a global biopharmaceutical company, announced the closing of a $250.0 million credit facility in connection with the financing of its acquisition of R-Tech Ueno. The loans under the credit facility were fully allocated...
Read Story
October 23, 2015, 07:19 AM
|
Horizon Technology Finance Corporation closed a new $6.3 million venture loan to an existing portfolio company, New Haven Pharmaceuticals, Inc. (“NHP”), a privately held specialty pharmaceuticals company.NHP will use the proceeds of the venture loan...
Read Story
October 07, 2015, 07:36 AM
|
Jaguar Animal Health, Inc., an animal health company focused on developing and commercializing first-in-class gastrointestinal products for companion and production animals, announced it has obtained a senior secured term loan facility for up to $8...
Read Story
August 24, 2015, 07:11 AM
|
Brown Gibbons Lang & Company (BGL) announced the sale of Celsis International Ltd. (Celsis) to Charles River Laboratories International, Inc. for $212 million in cash. BGL's Healthcare & Life Sciences team served as the exclusive financial advisor to...
Read Story
|
Sarepta Therapeutics, Inc., a developer of innovative RNA-targeted therapeutics, entered into a credit and security agreement with MidCap Financial, a middle market-focused, specialty finance firm, that establishes a senior secured term loan facility...
Read Story
|
Imprimis Pharmaceuticals, Inc., a pharmaceutical company focused on the development and commercialization of proprietary compounded drug formulations, has entered into a loan agreement with IMMY Funding LLC, an affiliate of Life Sciences Alternative...
Read Story
|
Lannett Company, Inc. announced that it has amended and increased its five-year revolving credit facility to $120 million from $50 million. The amended facility includes an accordion feature that will allow the company to increase borrowings by a...
Read Story
|
Melinta Therapeutics has entered into a $30 million growth capital debt financing agreement with Hercules Technology Growth Capital, Inc. The initial funding of $20 million closed in December 2014. Melinta has the option, under the terms of the...
Read Story
February 10, 2015, 07:13 AM
|
With over 4,500 assets formerly owned by Ameridose about to hit the block, an online-only medical/pharmaceutical auction of impressive proportions is currently taking shape. This five day event will be taking place online via webcast starting...
Read Story
January 28, 2015, 07:18 AM
|
ADMA Biologics, Inc., a late-stage biopharmaceutical company that develops, manufactures, and intends to market specialty plasma-based biologics for the treatment and prevention of certain infectious diseases, announced that it has received a $5...
Read Story
December 16, 2014, 07:31 AM
|
Urigen Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development of treatments for urological disorders and pain, announced the successful completion on June 23, 2014 of the restructuring proposed to and approved by its...
Read Story
|
Nanotherapeutics, Inc., an integrated biopharmaceutical company with a focus on advanced development and manufacturing, announced that it has secured a $30 million loan facility from Hercules Technology Growth Capital, Inc. The funds from the loan...
Read Story
|
Deerfield Management Company announced it has committed to invest up to $60 million in KemPharm, Inc. through a $10 million senior secured convertible note and a $50 million senior secured term debt facility. The facility provides KemPharm with...
Read Story
|
Relypsa, Inc., a biopharmaceutical company, announced it has secured a loan facility of up to $35 million with Oxford Finance LLC ("Oxford") and Silicon Valley Bank ("SVB").Under the terms of the agreement, the company immediately drew $15 million...
Read Story
|
Omega Commercial Finance Corporation , the parent company to Capital MatchPointTM, announces their plans to launch an alternative finance division solely focused on the international and domestic legalized cannabis medical marijuana market through a...
Read Story
|
Navidea Biopharmaceuticals, Inc., a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, announced that it has closed a $30 million non-dilutive loan transaction with Oxford Finance LLC (“Oxford”). The loan funds will be...
Read Story
|
InnoPharma, Inc. announced that it has closed on a $20 million term loan facility, provided by Athyrium Capital Management through its Athyrium Opportunities Fund. Proceeds will support the company's ongoing development of complex generic and...
Read Story
November 14, 2013, 07:21 AM
|
Salix Pharmaceuticals, Ltd. and Santarus, Inc. announced that the companies have entered into a definitive merger agreement under which Salix will acquire all of the outstanding common stock of Santarus for $32.00 per share in cash (without interest)...
Read Story
November 08, 2013, 07:25 AM
|
Furiex Pharmaceuticals, Inc. has executed a $15 million debt financing transaction with Fred Eshelman, Pharm.D., chairman and a 27.5% shareholder of Furiex. In parallel, Furiex has also entered into a Second Amended and Restated Loan and Security...
Read Story
October 01, 2013, 07:29 AM
|
Monroe Capital LLC announced the funding of a $75 million senior secured credit facility to support the growth of Alora Pharmaceuticals, LLC ("Alora"), the parent company of Avion Pharmaceuticals, LLC and Acella Pharmaceuticals, LLC. Based in...
Read Story
September 17, 2013, 07:57 AM
|
US Capital Partners, LLC has provided expansive term loan financing for Chantilly BioPharma, LLC, headquartered in Chantilly, VA. US Capital Partners is a private investment bank that makes direct debt investments, participates in debt facilities...
Read Story
August 14, 2013, 07:39 AM
|
BioDelivery Sciences International, Inc. secured a $20.0 million senior secured loan from an affiliate of MidCap Financial, LLC.The proceeds of the loan strengthens the cash position as BDSI moves toward the submission of a New Drug Application (NDA)...
Read Story
|